Qilai Long
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Immunology
- Cancer Research top 10%
- Oncology
- Topics
- Renal cell carcinoma treatment (20 papers)Renal and related cancers (15 papers)Epigenetics and DNA Methylation (6 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Qilai Long
33 papers receiving 788 citations
Peers
Comparison fields: 5 of 80
- Molecular Biology 422
- Pulmonary and Respiratory Medicine 248
- Immunology 169
- Cancer Research 169
- Oncology 150
Countries citing papers authored by Qilai Long
This map shows the geographic impact of Qilai Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qilai Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qilai Long more than expected).
Fields of papers citing papers by Qilai Long
This network shows the impact of papers produced by Qilai Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qilai Long. The network helps show where Qilai Long may publish in the future.
Co-authorship network of co-authors of Qilai Long
This figure shows the co-authorship network connecting the top 25 collaborators of Qilai Long. A scholar is included among the top collaborators of Qilai Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qilai Long. Qilai Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 88 | |
| 2 | 20 | |
| 3 | 12 | |
| 4 | 18 | |
| 5 | 90 | |
| 6 | 6 | |
| 7 | 85 | |
| 8 | 28 | |
| 9 | 5 | |
| 10 | 7 | |
| 11 | 16 | |
| 12 | 18 | |
| 13 | 2 | |
| 14 | 70 | |
| 15 | 13 | |
| 16 | 4 | |
| 17 | 8 | |
| 18 | 11 | |
| 19 | 24 | |
| 20 | 22 |
About Qilai Long
Qilai Long is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Molecular Biology, having authored 34 papers that have together received 798 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (20 papers), Renal and related cancers (15 papers) and Epigenetics and DNA Methylation (6 papers). The work is most often cited by research in Cancer Research (169 citations), Immunology (169 citations) and Pulmonary and Respiratory Medicine (248 citations). Qilai Long has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Jianming Guo, Li Liu, Jiejie Xu, Yu Xia, Qi Bai, Wei Xi, Hang Wang, Qixia Xu, Da Fu and Yu Sun. Their work appears in journals such as Nature Communications, PLoS ONE and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.